RBP4 and diabetic kidney disease: Furthermore, measurement of urinary afamin and RBP4 may serve as biomarkers for the accurate diagnosis of diabetic nephropathy and might help to reduce the burden associated with renal biopsy in patients with diabetic nephropathy [38].